2019 International Congress Archives - Page 50 of 217

1:45pm-3:15pm: Posterior cortical atrophy (PCA) attributable to corticobasal degeneration

H. Sienkiewicz-Jarosz, E. Bucior (Warsaw, Poland)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Postural Abnormalities in Parkinson’s Disease: an Epidemiological and Clinical Multicenter Study

C. Geroin, M. Gandolfi, R. Ceravolo, M. Capecci, E. Andrenelli, M. Ceravolo, L. Bonanni, M. Onofrj, M. Vitale, M. Catalan, P. Polverino, C. Bertolotti, S. Mazzucchi, S. Giannoni, N. Smania, S. Tamburin, L. Vacca, F. Stocchi, F. Radicati, C. Artusi, M. Zibetti, L. Lopiano, A. Fasano, M. Tinazzi (Verona, Italy)

Dystonia · Les Muses Terrace, Level 3

1:45pm-3:15pm: Postural alterations in patients with Progressive Supranuclear Palsy

C. Palmisano, M. Todisco, V. Maltese, R. Cilia, N. Pozzi, A. Canessa, M. Canesi, J. Volkmann, C. Frigo, G. Pezzoli, I. Isaias (Würzburg, Germany)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Postural instability secondary to hypoxic injury to the bilateral globus pallidi

D. Shpiner, J. Margolesky, H. Moore (Miami, FL, USA)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Pramipexole regulates the depressive-like symptom through dopamine D3 not dopamine D2 receptor in a mouse model of Parkinson’s disease

SZ. Wei, F. Wang, CF. Liu (Suzhou, China)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Predicting domain specific cognitive impairment in Parkinson’s disease

P. Zarifkar, J. Kim, C. La, P. Borghammer, K. Poston (Palo Alto, CA, USA)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Predicting the impact of Parkinson’s disease on a patient’s gait: the potential of innovative approaches based on instrumented clinical tests

K. Lebel, C. Duval, E. Goubault, S. Bogard (Montréal, QC, Canada)

Rating Scales · Les Muses Terrace, Level 3

1:45pm-3:15pm: Predictors of quality of life in dystonia – a longitudinal study

J. Junker, J. Hall, B. Berman, M. Vidailhet, E. Roze, I. Malaty, J. Jankovic, S. Reich, A. Espay, N. Patel, J. Perlmutter, H. Jinnah, V. Brandt, N. Brueggemann (Luebeck, Germany)

Dystonia · Les Muses Terrace, Level 3

1:45pm-3:15pm: Predictors of Retention for Carbidopa/Levodopa Intestinal Gel in Parkinson Disease

A. Nagy, T. Davis, T. Hassell, P. Hedera, D. Isaacs, H. Koons, F. Phibbs, S. Afrow, J. Fang (Nashville, TN, USA)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Preferred place of death (PPOD) in PD, PSP and MSA

C. Morris, R. Walker, M. Lee, J. Adamson (Newcastle, United Kingdom)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3